We are live on ! Find out more
FRC

First Republic Bank

Delisted

FRC was delisted on the 28th of April, 2023.

11 hedge funds and large institutions have $9 invested in First Republic Bank in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% less funds holding

Funds holding: 1511 (-4)

47% less capital invested

Capital invested by funds: $17 → $9 (-$8)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
11
Holders Change
-4
Holders Change %
-26.67%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
6
Calls
Puts
Net Calls
Net Calls Change

FRC Hedge Fund Activity: Q1 2025 in Review

11 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in First Republic Bank (FRC) for Q1 2025, worth a combined $9 — down 47% from $17 a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FRC and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Brooklyn Investment Group, opening a new position worth an estimated $1. The largest seller was Avior Wealth Management, exiting entirely with an estimated $5 sold.

  • 11 institutional investors held First Republic Bank (FRC) as of Q1 2025, down from 15 in Q4 2024.
  • Funds reported $9 of First Republic Bank stock for Q1 2025, down 47% quarter-over-quarter.
  • 2 funds opened new First Republic Bank positions in Q1 2025 and 6 closed out, a net change of -4 holders.
  • The largest First Republic Bank buyer in Q1 2025 was Brooklyn Investment Group, an estimated $1 added.
  • The largest First Republic Bank seller in Q1 2025 was Avior Wealth Management, an estimated $5 sold.

Based on aggregated 13F filings for Q1 2025.